TRANSCEND FL Trial Updates with Dr. Manali Kamdar
SpotifyTRANSCEND FL is a global trial assessing the efficacy and safety of the CAR T cell therapy lisocabtagene maraleucel in patients with relapsed or refractory follicular lymphoma. Join Dr. Kamdar, the lead investigator for this trial at University of Colorado Cancer Center, for this podcast to learn more. Feel free to email me with thoughts or questions on this podcast at hannah@healthtree.org.
For additional CAR T resources, see below.
HealthTree University:
- What is CAR-T therapy and how is this drug class used to treat follicular lymphoma?
- What is some of the most promising research being done for follicular lymphoma?
- What are my options for treating follicular lymphoma?
News Articles:
101 Pages:
Hannah Loosle
Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding. Hannah enjoys baking and going to concerts in her free time.
Manali Kamdar, MD
Dr. Manali Kamdar completed her medical school training in Mumbai, India and attended East Carolina University for her Internal Medicine Residency and her Hematology Oncology Fellowship. She then completed another Fellowship in Blood and Marrow transplantation at Stanford University. In November 2014 she joined the Division of Hematology at the University of Colorado and is presently the Clinical Director of Lymphoma Services. She is a clinical researcher in malignant hematology with a focus on lymphomas and autologous transplantation. She conducts clinical trials with novel agents and chemotherapy with the hope of improving outcomes in the field of lymphoproliferative malignancies.
